nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.193	0.272	CbGbCtD
Tolbutamide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.135	0.19	CbGbCtD
Tolbutamide—CYP2C8—Progesterone—uterine cancer	0.128	0.18	CbGbCtD
Tolbutamide—CYP2C19—Progesterone—uterine cancer	0.107	0.151	CbGbCtD
Tolbutamide—CYP2C9—Progesterone—uterine cancer	0.0893	0.126	CbGbCtD
Tolbutamide—CYP2C8—Etoposide—uterine cancer	0.0573	0.0807	CbGbCtD
Tolbutamide—Digestion impaired—Progesterone—uterine cancer	0.00564	0.0603	CcSEcCtD
Tolbutamide—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.00511	0.0546	CcSEcCtD
Tolbutamide—Heartburn—Medroxyprogesterone Acetate—uterine cancer	0.00497	0.0531	CcSEcCtD
Tolbutamide—KCNJ1—renal system—uterine cancer	0.00492	0.0697	CbGeAlD
Tolbutamide—Gliclazide—VEGFA—uterine cancer	0.00468	1	CrCbGaD
Tolbutamide—Eruption—Dactinomycin—uterine cancer	0.00434	0.0463	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Progesterone—uterine cancer	0.00429	0.0459	CcSEcCtD
Tolbutamide—ABCC8—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.00427	0.0354	CbGpPWpGaD
Tolbutamide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.00414	0.0344	CbGpPWpGaD
Tolbutamide—CYP2C18—uterine cervix—uterine cancer	0.00399	0.0564	CbGeAlD
Tolbutamide—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.00389	0.0416	CcSEcCtD
Tolbutamide—ABCC8—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00379	0.0314	CbGpPWpGaD
Tolbutamide—CYP2C18—mammalian vulva—uterine cancer	0.00349	0.0494	CbGeAlD
Tolbutamide—KCNJ1—Potassium Channels—ABCC9—uterine cancer	0.0033	0.0274	CbGpPWpGaD
Tolbutamide—ABCC8—smooth muscle tissue—uterine cancer	0.00286	0.0404	CbGeAlD
Tolbutamide—SLC15A1—epithelium—uterine cancer	0.00283	0.0401	CbGeAlD
Tolbutamide—ABCC8—renal system—uterine cancer	0.00275	0.0389	CbGeAlD
Tolbutamide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.0294	CcSEcCtD
Tolbutamide—CYP2C18—vagina—uterine cancer	0.0027	0.0382	CbGeAlD
Tolbutamide—ABCC8—endometrium—uterine cancer	0.00266	0.0376	CbGeAlD
Tolbutamide—SLC15A1—renal system—uterine cancer	0.00263	0.0372	CbGeAlD
Tolbutamide—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.0272	CcSEcCtD
Tolbutamide—SLC15A1—endometrium—uterine cancer	0.00254	0.036	CbGeAlD
Tolbutamide—Aplastic anaemia—Dactinomycin—uterine cancer	0.0025	0.0267	CcSEcCtD
Tolbutamide—SLC15A1—mammalian vulva—uterine cancer	0.00246	0.0348	CbGeAlD
Tolbutamide—KCNJ11—female reproductive system—uterine cancer	0.00239	0.0338	CbGeAlD
Tolbutamide—Abdominal distension—Progesterone—uterine cancer	0.00238	0.0254	CcSEcCtD
Tolbutamide—SLCO2B1—decidua—uterine cancer	0.00219	0.031	CbGeAlD
Tolbutamide—KCNJ11—female gonad—uterine cancer	0.00218	0.0308	CbGeAlD
Tolbutamide—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.0231	CcSEcCtD
Tolbutamide—SLCO2B1—renal system—uterine cancer	0.00215	0.0305	CbGeAlD
Tolbutamide—SLCO1A2—renal system—uterine cancer	0.00198	0.028	CbGeAlD
Tolbutamide—SLCO2B1—uterus—uterine cancer	0.00192	0.0271	CbGeAlD
Tolbutamide—SLC15A1—vagina—uterine cancer	0.0019	0.0269	CbGeAlD
Tolbutamide—SLCO1A2—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.00183	0.0152	CbGpPWpGaD
Tolbutamide—Eruption—Epirubicin—uterine cancer	0.00176	0.0188	CcSEcCtD
Tolbutamide—SLC15A2—uterine cervix—uterine cancer	0.00176	0.0249	CbGeAlD
Tolbutamide—SLCO2B1—female reproductive system—uterine cancer	0.00172	0.0244	CbGeAlD
Tolbutamide—ABCC8—Potassium Channels—ABCC9—uterine cancer	0.00169	0.014	CbGpPWpGaD
Tolbutamide—Erythema—Progesterone—uterine cancer	0.00165	0.0176	CcSEcCtD
Tolbutamide—SLC15A2—renal system—uterine cancer	0.00164	0.0233	CbGeAlD
Tolbutamide—KCNJ11—Potassium Channels—ABCC9—uterine cancer	0.00163	0.0136	CbGpPWpGaD
Tolbutamide—Eruption—Doxorubicin—uterine cancer	0.00163	0.0174	CcSEcCtD
Tolbutamide—SLC15A2—endometrium—uterine cancer	0.00159	0.0225	CbGeAlD
Tolbutamide—Pancytopenia—Dactinomycin—uterine cancer	0.00159	0.017	CcSEcCtD
Tolbutamide—SLCO2B1—female gonad—uterine cancer	0.00157	0.0222	CbGeAlD
Tolbutamide—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.016	CcSEcCtD
Tolbutamide—KCNJ1—Neuronal System—ABCC9—uterine cancer	0.00144	0.012	CbGpPWpGaD
Tolbutamide—SLCO1A2—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	0.00141	0.0117	CbGpPWpGaD
Tolbutamide—KCNJ11—lymph node—uterine cancer	0.0014	0.0198	CbGeAlD
Tolbutamide—Agranulocytosis—Dactinomycin—uterine cancer	0.00139	0.0149	CcSEcCtD
Tolbutamide—CYP2C8—renal system—uterine cancer	0.00138	0.0196	CbGeAlD
Tolbutamide—CYP2C8—endometrium—uterine cancer	0.00134	0.0189	CbGeAlD
Tolbutamide—SLC15A2—female reproductive system—uterine cancer	0.00132	0.0186	CbGeAlD
Tolbutamide—Jaundice cholestatic—Epirubicin—uterine cancer	0.00123	0.0131	CcSEcCtD
Tolbutamide—SLC15A2—female gonad—uterine cancer	0.0012	0.017	CbGeAlD
Tolbutamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.0128	CcSEcCtD
Tolbutamide—SLC15A2—vagina—uterine cancer	0.00119	0.0168	CbGeAlD
Tolbutamide—Dyspepsia—Progesterone—uterine cancer	0.00118	0.0127	CcSEcCtD
Tolbutamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00117	0.00974	CbGpPWpGaD
Tolbutamide—Erythema—Dactinomycin—uterine cancer	0.00117	0.0124	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00116	0.0124	CcSEcCtD
Tolbutamide—CYP2C18—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00116	0.00961	CbGpPWpGaD
Tolbutamide—Pancytopenia—Etoposide—uterine cancer	0.00115	0.0123	CcSEcCtD
Tolbutamide—CYP2C19—vagina—uterine cancer	0.00115	0.0163	CbGeAlD
Tolbutamide—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00114	0.0122	CcSEcCtD
Tolbutamide—CYP2C8—female reproductive system—uterine cancer	0.00111	0.0157	CbGeAlD
Tolbutamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.0115	CcSEcCtD
Tolbutamide—Urticaria—Progesterone—uterine cancer	0.00107	0.0114	CcSEcCtD
Tolbutamide—CYP2C18—Tryptophan metabolism—CYP19A1—uterine cancer	0.00107	0.00886	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.0112	CcSEcCtD
Tolbutamide—Leukopenia—Dactinomycin—uterine cancer	0.00104	0.0111	CcSEcCtD
Tolbutamide—Aplastic anaemia—Epirubicin—uterine cancer	0.00102	0.0108	CcSEcCtD
Tolbutamide—SLCO2B1—lymph node—uterine cancer	0.00101	0.0143	CbGeAlD
Tolbutamide—Agranulocytosis—Etoposide—uterine cancer	0.00101	0.0108	CcSEcCtD
Tolbutamide—CYP2C8—vagina—uterine cancer	0.001	0.0142	CbGeAlD
Tolbutamide—CYP2C9—female reproductive system—uterine cancer	0.000985	0.0139	CbGeAlD
Tolbutamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000969	0.0103	CcSEcCtD
Tolbutamide—Pruritus—Progesterone—uterine cancer	0.000952	0.0102	CcSEcCtD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000951	0.00789	CbGpPWpGaD
Tolbutamide—Aplastic anaemia—Doxorubicin—uterine cancer	0.00094	0.01	CcSEcCtD
Tolbutamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.000932	0.00995	CcSEcCtD
Tolbutamide—CYP2C18—Metapathway biotransformation—AKR1B10—uterine cancer	0.000895	0.00743	CbGpPWpGaD
Tolbutamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000863	0.00922	CcSEcCtD
Tolbutamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000863	0.00716	CbGpPWpGaD
Tolbutamide—CYP2C18—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000852	0.00707	CbGpPWpGaD
Tolbutamide—Rash—Progesterone—uterine cancer	0.000849	0.00906	CcSEcCtD
Tolbutamide—Headache—Progesterone—uterine cancer	0.000843	0.00901	CcSEcCtD
Tolbutamide—CYP2C18—Metapathway biotransformation—AKR1B1—uterine cancer	0.000832	0.00691	CbGpPWpGaD
Tolbutamide—Hypoglycaemia—Epirubicin—uterine cancer	0.000805	0.00859	CcSEcCtD
Tolbutamide—Nausea—Progesterone—uterine cancer	0.0008	0.00854	CcSEcCtD
Tolbutamide—Hyponatraemia—Epirubicin—uterine cancer	0.000788	0.00842	CcSEcCtD
Tolbutamide—SLC15A2—lymph node—uterine cancer	0.00077	0.0109	CbGeAlD
Tolbutamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000769	0.00821	CcSEcCtD
Tolbutamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000764	0.00816	CcSEcCtD
Tolbutamide—Leukopenia—Etoposide—uterine cancer	0.000755	0.00807	CcSEcCtD
Tolbutamide—Hypoglycaemia—Doxorubicin—uterine cancer	0.000745	0.00795	CcSEcCtD
Tolbutamide—CYP2C18—FOXA1 transcription factor network—ESR1—uterine cancer	0.000739	0.00613	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—ABCC9—uterine cancer	0.000736	0.00611	CbGpPWpGaD
Tolbutamide—Hyponatraemia—Doxorubicin—uterine cancer	0.00073	0.00779	CcSEcCtD
Tolbutamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000724	0.00774	CcSEcCtD
Tolbutamide—KCNJ11—Neuronal System—ABCC9—uterine cancer	0.000713	0.00592	CbGpPWpGaD
Tolbutamide—ABCC8—Integration of energy metabolism—STK11—uterine cancer	0.000713	0.00592	CbGpPWpGaD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000699	0.00581	CbGpPWpGaD
Tolbutamide—KCNJ11—Integration of energy metabolism—STK11—uterine cancer	0.000692	0.00574	CbGpPWpGaD
Tolbutamide—Abdominal distension—Epirubicin—uterine cancer	0.000683	0.0073	CcSEcCtD
Tolbutamide—Thrombocytopenia—Etoposide—uterine cancer	0.000674	0.0072	CcSEcCtD
Tolbutamide—Pancytopenia—Epirubicin—uterine cancer	0.000645	0.00688	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—uterine cancer	0.000632	0.00675	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Epirubicin—uterine cancer	0.00062	0.00662	CcSEcCtD
Tolbutamide—CYP2C18—Metapathway biotransformation—AKR1C1—uterine cancer	0.000611	0.00507	CbGpPWpGaD
Tolbutamide—Rash—Dactinomycin—uterine cancer	0.0006	0.00641	CcSEcCtD
Tolbutamide—Pancytopenia—Doxorubicin—uterine cancer	0.000596	0.00637	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000594	0.00635	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000573	0.00612	CcSEcCtD
Tolbutamide—Nausea—Dactinomycin—uterine cancer	0.000565	0.00604	CcSEcCtD
Tolbutamide—Agranulocytosis—Epirubicin—uterine cancer	0.000565	0.00603	CcSEcCtD
Tolbutamide—Urticaria—Etoposide—uterine cancer	0.000547	0.00584	CcSEcCtD
Tolbutamide—CYP2C18—Metapathway biotransformation—GPX3—uterine cancer	0.000536	0.00445	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000533	0.00443	CbGpPWpGaD
Tolbutamide—Agranulocytosis—Doxorubicin—uterine cancer	0.000523	0.00558	CcSEcCtD
Tolbutamide—CYP2C18—Biological oxidations—CYP11A1—uterine cancer	0.000505	0.00419	CbGpPWpGaD
Tolbutamide—CYP2C18—FOXA1 transcription factor network—CDKN1B—uterine cancer	0.000502	0.00417	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—CYP11A1—uterine cancer	0.000498	0.00414	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000488	0.00405	CbGpPWpGaD
Tolbutamide—Pruritus—Etoposide—uterine cancer	0.000487	0.0052	CcSEcCtD
Tolbutamide—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000482	0.004	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000476	0.00395	CbGpPWpGaD
Tolbutamide—Erythema—Epirubicin—uterine cancer	0.000473	0.00505	CcSEcCtD
Tolbutamide—CYP2C18—Metapathway biotransformation—AKR1C3—uterine cancer	0.00047	0.00391	CbGpPWpGaD
Tolbutamide—CYP2C18—FOXA1 transcription factor network—EP300—uterine cancer	0.000441	0.00366	CbGpPWpGaD
Tolbutamide—Erythema—Doxorubicin—uterine cancer	0.000438	0.00467	CcSEcCtD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000436	0.00362	CbGpPWpGaD
Tolbutamide—Rash—Etoposide—uterine cancer	0.000434	0.00464	CcSEcCtD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000434	0.0036	CbGpPWpGaD
Tolbutamide—Headache—Etoposide—uterine cancer	0.000431	0.00461	CcSEcCtD
Tolbutamide—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00043	0.00357	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000426	0.00353	CbGpPWpGaD
Tolbutamide—Leukopenia—Epirubicin—uterine cancer	0.000423	0.00452	CcSEcCtD
Tolbutamide—Nausea—Etoposide—uterine cancer	0.000409	0.00437	CcSEcCtD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000397	0.0033	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000396	0.00329	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000396	0.00328	CbGpPWpGaD
Tolbutamide—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000392	0.00326	CbGpPWpGaD
Tolbutamide—Leukopenia—Doxorubicin—uterine cancer	0.000392	0.00418	CcSEcCtD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00038	0.00315	CbGpPWpGaD
Tolbutamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000378	0.00404	CcSEcCtD
Tolbutamide—CYP2C8—Metapathway biotransformation—AKR1B10—uterine cancer	0.000373	0.00309	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—CYP19A1—uterine cancer	0.000372	0.00309	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—CYP19A1—uterine cancer	0.000366	0.00304	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000359	0.00298	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000356	0.00296	CbGpPWpGaD
Tolbutamide—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000354	0.00294	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000353	0.00293	CbGpPWpGaD
Tolbutamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.00035	0.00373	CcSEcCtD
Tolbutamide—CYP2C8—Metapathway biotransformation—AKR1B1—uterine cancer	0.000347	0.00288	CbGpPWpGaD
Tolbutamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000342	0.00284	CbGpPWpGaD
Tolbutamide—Dyspepsia—Epirubicin—uterine cancer	0.00034	0.00363	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000333	0.00356	CcSEcCtD
Tolbutamide—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	0.000333	0.00276	CbGpPWpGaD
Tolbutamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000332	0.00275	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000331	0.00274	CbGpPWpGaD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000322	0.00267	CbGpPWpGaD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000321	0.00266	CbGpPWpGaD
Tolbutamide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000316	0.00263	CbGpPWpGaD
Tolbutamide—Dyspepsia—Doxorubicin—uterine cancer	0.000314	0.00336	CcSEcCtD
Tolbutamide—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	0.000309	0.00257	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000308	0.00329	CcSEcCtD
Tolbutamide—Urticaria—Epirubicin—uterine cancer	0.000307	0.00327	CcSEcCtD
Tolbutamide—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.000303	0.00252	CbGpPWpGaD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000292	0.00243	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000291	0.00242	CbGpPWpGaD
Tolbutamide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000288	0.0024	CbGpPWpGaD
Tolbutamide—Urticaria—Doxorubicin—uterine cancer	0.000284	0.00303	CcSEcCtD
Tolbutamide—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.000282	0.00234	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000275	0.00228	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000275	0.00228	CbGpPWpGaD
Tolbutamide—Pruritus—Epirubicin—uterine cancer	0.000273	0.00292	CcSEcCtD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000261	0.00217	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00026	0.00216	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SRD5A2—uterine cancer	0.000256	0.00213	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NDUFB11—uterine cancer	0.000256	0.00213	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	0.000254	0.00211	CbGpPWpGaD
Tolbutamide—Pruritus—Doxorubicin—uterine cancer	0.000253	0.0027	CcSEcCtD
Tolbutamide—KCNJ11—Metabolism—SRD5A2—uterine cancer	0.000249	0.00206	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NDUFB11—uterine cancer	0.000249	0.00206	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000245	0.00204	CbGpPWpGaD
Tolbutamide—Rash—Epirubicin—uterine cancer	0.000243	0.0026	CcSEcCtD
Tolbutamide—Headache—Epirubicin—uterine cancer	0.000242	0.00258	CcSEcCtD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000237	0.00197	CbGpPWpGaD
Tolbutamide—Nausea—Epirubicin—uterine cancer	0.000229	0.00245	CcSEcCtD
Tolbutamide—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.000227	0.00188	CbGpPWpGaD
Tolbutamide—Rash—Doxorubicin—uterine cancer	0.000225	0.0024	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—uterine cancer	0.000224	0.00239	CcSEcCtD
Tolbutamide—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	0.000223	0.00185	CbGpPWpGaD
Tolbutamide—Nausea—Doxorubicin—uterine cancer	0.000212	0.00227	CcSEcCtD
Tolbutamide—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	0.00021	0.00175	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	0.000207	0.00172	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000207	0.00172	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000202	0.00167	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NDUFB11—uterine cancer	0.0002	0.00166	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SRD5A2—uterine cancer	0.0002	0.00166	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	0.000199	0.00165	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	0.000196	0.00163	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	0.000188	0.00156	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000187	0.00155	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKR1B1—uterine cancer	0.000185	0.00154	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—STAR—uterine cancer	0.000185	0.00154	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	0.000185	0.00154	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	0.000182	0.00151	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—STAR—uterine cancer	0.00018	0.00149	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKR1B1—uterine cancer	0.00018	0.00149	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	0.000175	0.00145	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—HRAS—uterine cancer	0.000173	0.00144	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	0.000171	0.00142	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SRD5A2—uterine cancer	0.000169	0.0014	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NDUFB11—uterine cancer	0.000169	0.0014	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	0.000169	0.0014	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000167	0.00138	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000164	0.00136	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	0.000159	0.00132	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000155	0.00129	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	0.000155	0.00128	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	0.000153	0.00127	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000152	0.00126	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—POLD1—uterine cancer	0.000145	0.00121	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKR1B1—uterine cancer	0.000144	0.0012	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—STAR—uterine cancer	0.000144	0.0012	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—POLD1—uterine cancer	0.000141	0.00117	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	0.000138	0.00115	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	0.000136	0.00113	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKR1C1—uterine cancer	0.000136	0.00113	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000135	0.00112	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000135	0.00112	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKR1C1—uterine cancer	0.000132	0.00109	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	0.000126	0.00105	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	0.000124	0.00103	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—STAR—uterine cancer	0.000122	0.00102	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKR1B1—uterine cancer	0.000122	0.00102	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—RRM2—uterine cancer	0.000121	0.00101	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000121	0.001	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00012	0.001	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00012	0.001	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—DCN—uterine cancer	0.000118	0.000977	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—RRM2—uterine cancer	0.000118	0.000976	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—DCN—uterine cancer	0.000114	0.000947	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—POLD1—uterine cancer	0.000113	0.00094	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP11A1—uterine cancer	0.000111	0.00092	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00011	0.000912	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00011	0.000912	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP11A1—uterine cancer	0.000108	0.000893	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKR1C1—uterine cancer	0.000106	0.00088	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKR1C3—uterine cancer	0.000105	0.000869	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKR1C3—uterine cancer	0.000102	0.000843	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.9e-05	0.000822	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—POLD1—uterine cancer	9.59e-05	0.000797	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—RRM2—uterine cancer	9.44e-05	0.000784	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—DCN—uterine cancer	9.17e-05	0.000761	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKR1C1—uterine cancer	8.97e-05	0.000745	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.84e-05	0.000734	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—HRAS—uterine cancer	8.84e-05	0.000734	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP11A1—uterine cancer	8.64e-05	0.000717	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—HRAS—uterine cancer	8.57e-05	0.000712	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NDUFB11—uterine cancer	8.31e-05	0.00069	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SRD5A2—uterine cancer	8.31e-05	0.00069	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—STK11—uterine cancer	8.16e-05	0.000677	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP19A1—uterine cancer	8.16e-05	0.000677	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKR1C3—uterine cancer	8.16e-05	0.000677	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.07e-05	0.00067	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.06e-05	0.000669	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—RRM2—uterine cancer	8e-05	0.000664	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—STK11—uterine cancer	7.91e-05	0.000657	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP19A1—uterine cancer	7.91e-05	0.000657	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—DCN—uterine cancer	7.77e-05	0.000645	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.62e-05	0.000633	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NDUFB11—uterine cancer	7.42e-05	0.000616	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SRD5A2—uterine cancer	7.42e-05	0.000616	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP11A1—uterine cancer	7.32e-05	0.000607	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.21e-05	0.000598	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKR1C3—uterine cancer	6.91e-05	0.000574	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.8e-05	0.000565	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NDUFB11—uterine cancer	6.76e-05	0.000562	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SRD5A2—uterine cancer	6.76e-05	0.000562	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.57e-05	0.000545	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—STK11—uterine cancer	6.35e-05	0.000528	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP19A1—uterine cancer	6.35e-05	0.000528	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.2e-05	0.000515	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MTHFR—uterine cancer	6.13e-05	0.000509	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKR1B1—uterine cancer	6.01e-05	0.000499	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—STAR—uterine cancer	6.01e-05	0.000499	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MTHFR—uterine cancer	5.94e-05	0.000493	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.94e-05	0.000493	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP19A1—uterine cancer	5.38e-05	0.000447	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—STK11—uterine cancer	5.38e-05	0.000447	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKR1B1—uterine cancer	5.36e-05	0.000445	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—STAR—uterine cancer	5.36e-05	0.000445	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.3e-05	0.00044	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.05e-05	0.00042	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—STAR—uterine cancer	4.89e-05	0.000406	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKR1B1—uterine cancer	4.89e-05	0.000406	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.83e-05	0.000401	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.82e-05	0.0004	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MTHFR—uterine cancer	4.78e-05	0.000396	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—POLD1—uterine cancer	4.71e-05	0.000391	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKR1C1—uterine cancer	4.41e-05	0.000366	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—POLD1—uterine cancer	4.21e-05	0.000349	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MTHFR—uterine cancer	4.04e-05	0.000336	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKR1C1—uterine cancer	3.94e-05	0.000327	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—RRM2—uterine cancer	3.93e-05	0.000326	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—POLD1—uterine cancer	3.84e-05	0.000319	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—DCN—uterine cancer	3.82e-05	0.000317	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP11A1—uterine cancer	3.59e-05	0.000298	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKR1C1—uterine cancer	3.59e-05	0.000298	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.56e-05	0.000296	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—RRM2—uterine cancer	3.51e-05	0.000291	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTEN—uterine cancer	3.41e-05	0.000283	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—DCN—uterine cancer	3.41e-05	0.000283	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKR1C3—uterine cancer	3.39e-05	0.000282	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTEN—uterine cancer	3.31e-05	0.000275	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—EP300—uterine cancer	3.25e-05	0.00027	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP11A1—uterine cancer	3.21e-05	0.000266	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—RRM2—uterine cancer	3.2e-05	0.000266	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—EP300—uterine cancer	3.15e-05	0.000262	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—DCN—uterine cancer	3.11e-05	0.000258	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKR1C3—uterine cancer	3.03e-05	0.000252	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.93e-05	0.000243	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.76e-05	0.000229	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTEN—uterine cancer	2.66e-05	0.000221	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.64e-05	0.00022	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—STK11—uterine cancer	2.64e-05	0.00022	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—EP300—uterine cancer	2.53e-05	0.00021	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.48e-05	0.000206	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CA—uterine cancer	2.41e-05	0.0002	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.37e-05	0.000197	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP19A1—uterine cancer	2.36e-05	0.000196	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—STK11—uterine cancer	2.36e-05	0.000196	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CA—uterine cancer	2.33e-05	0.000194	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTEN—uterine cancer	2.25e-05	0.000187	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.22e-05	0.000184	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—STK11—uterine cancer	2.15e-05	0.000179	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.15e-05	0.000179	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—EP300—uterine cancer	2.15e-05	0.000178	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.11e-05	0.000175	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.02e-05	0.000168	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTHFR—uterine cancer	1.99e-05	0.000165	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKT1—uterine cancer	1.97e-05	0.000163	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.93e-05	0.00016	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKT1—uterine cancer	1.91e-05	0.000158	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CA—uterine cancer	1.87e-05	0.000156	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTHFR—uterine cancer	1.77e-05	0.000147	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.75e-05	0.000145	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTHFR—uterine cancer	1.62e-05	0.000134	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CA—uterine cancer	1.59e-05	0.000132	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.56e-05	0.00013	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKT1—uterine cancer	1.53e-05	0.000127	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.43e-05	0.000118	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKT1—uterine cancer	1.3e-05	0.000108	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTEN—uterine cancer	1.11e-05	9.18e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—EP300—uterine cancer	1.05e-05	8.75e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTEN—uterine cancer	9.87e-06	8.19e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—EP300—uterine cancer	9.41e-06	7.81e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTEN—uterine cancer	9e-06	7.47e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—EP300—uterine cancer	8.58e-06	7.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CA—uterine cancer	7.8e-06	6.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CA—uterine cancer	6.96e-06	5.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKT1—uterine cancer	6.37e-06	5.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CA—uterine cancer	6.35e-06	5.27e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKT1—uterine cancer	5.69e-06	4.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKT1—uterine cancer	5.19e-06	4.31e-05	CbGpPWpGaD
